Monoclonal antibodies in the treatment of chronic lymphocytic leukemia Nina Shih LiuSusan O’Brien Review Pages: 297 - 304
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer V. R. PaiT. MazumdarA. K. D’Cruz Original Article Pages: 305 - 308
Tamoxifen and megestrol acetate for postmenopausal breast cancer L. LöfgrenB. WallbergE. von Schoultz Original Article Pages: 309 - 318
Sequence variant in the intron 10 of the RET oncogene in a patient with microfollicular thyroid carcinoma with medullar differentiation Emilija VeljkovicRadan DzodicBogomir Dimitrijevic Original Article Pages: 319 - 323
Myelofibrosis in primary myelodysplastic syndromes D. MarisavljevićZ. RolovićM. Ćolović Original Article Pages: 325 - 331
Long-term survivors in myelodysplastic syndromes Dragomir MarisavljevićZoran RolovićMilica Čolović Original Article Pages: 333 - 338
Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model Paulus TsuiMarvin RubensteinPatrick Guinan Original Article Pages: 339 - 348
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate Mats HardlingYuan WeiAnne Ricksten Original Article Pages: 349 - 358
Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma Mustafa AltinbasOzlem ErMustafa Ozesmi Original Article Pages: 359 - 366
Acute leukemia in a patient with ocular melanoma Mustafa OzgurogluNuran BeseHalit Pazarlı Letter Pages: 373 - 374
